Vision behind Dianox

Eradicate deaths from undiagnosed diseases.


We care about people
We are engaged for a more sustainable way of living
We are goal orientated
We aim to make a large scale impact on health

We want to end the epidemics of infectious disease to ensure people can live healthy lives. Everyone in the Dianox team joined to make an impact on global health. Due to the increasing uncertainty in the world, we will face even more complex challenges in diagnostics in the future. In order address these challenges, we rely on creativity and humble curiosity to link scientific developments directly with real-world applications. We are driven by our purpose of providing access to diagnostic testing to those left in the dark.

We only use ethically sourced chemicals and biomaterials, meaning there is no animal testing involved in the development of our biotechnology. Unlike the vast majority of conventional diagnostic biotechnologies, which are grown on horses, rabbits, and other cute animals. Transitioning away from animal testing is central to achieving a more humane society, and it allows us to address sustainability in diagnostics.

Focus on high impact deadly infectious diseases

Hepatitis B, Tuberculosis and COVID-19 are some of the deadliest infectious diseases in the world. Together they account for millions of deaths per year, and are among the leading causes of death in the world. Lack of testing is the biggest barrier in containing the spread of these pathogens. We possess the vision to address testing needs – a diagnostic answer for these high impact deadly infectious diseases.

Hepatitis B is a life-threatening infection that attacks the liver. It puts people at high risk of death from severe scarring of the liver (cirrhosis) and liver cancer. 257 million people are living with Hepatitis B, but only 10% have been diagnosed. It is a major global health problem.

Hepatitis B can go undetected for decades in many cases. The longer it is left untreated, the more susceptible the individual is to developing cirrhosis and liver cancer.

Hepatitis B diagnosis B today relies on a blood test, and in some cases also ultrasound imaging and liver biopsy.

Hepatitis B in the liver

Tuberculosis (TB) is an airborne disease caused by bacteria that attack the lungs. Without proper treatment nearly half of people die from this disease. 1,9 billion people are living with TB, and 80% have been diagnosed. TB does occur in every part of the world despite living conditions.

Common symptoms of TB are cough with blood, chest pains, weakness, weight loss, fever and night sweats.

TB diagnosis today relies on a skin test, and it is particularly difficult to diagnose in children.

Tuberculosis in the lungs

COVID-19 is a respiratory disease caused by a newly discovered coronavirus. There are currently no available treatment, vaccine or cure for COVID-19. 50 million people have been infected so far, and the numbers are increasing every day.

It is unknown how many have been diagnosed. It has quickly spread to every part of the world.
COVID-19 spreads through respiratory droplets that remain suspended in the air over long distances.

COVID-19 diagnosis today relies on a sputum test that takes several days to produce a result.


The world will face an increasing number of pandemic threats due to globalization, climate crisis, forced displacement, etc. While there are several diagnostic tools available, most are not scalable. There is an urgent need for radical innovation in diagnostics to enable broad screening of populations.


Would you like to know more about our technology and its applications?
Button to access the technology page.
Contact us